Labcorp Holdings Inc.
328.95USD
-0.9800 (-0.30%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on LH.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $4.64▲ | $4.61 | 0 | 2 |
| Next quarter | $4.47▲ | $4.4 | 2 | 0 |
| Current year | $18.35▲ | $18.01 | 3 | 0 |
| Next year | $19.78▲ | $19.41 | 3 | 3 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $4.77 | $4.99 | +0.22 (+4.6%) |
| 2026-03-31 | $4.12 | $4.25 | +0.13 (+3.3%) |
| 2025-12-31 | $3.94 | $4.07 | +0.13 (+3.2%) |
| 2025-09-30 | $4.14 | $4.18 | +0.04 (+1.0%) |
256 ratings from 33 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $350 $365 | Sep 21, 2026 |
| UBS | Maintained | Buy | $361 $380 | Sep 11, 2026 |
| Barclays | Maintained | Equal-Weight | $320 $330 | Sep 11, 2026 |
| Piper Sandler | Maintained | Neutral | $300 $309 | Aug 4, 2026 |
| JP Morgan | Maintained | Overweight | $330 $360 | Aug 3, 2026 |
| Morgan Stanley | Maintained | Overweight | $308 $338 | Jul 31, 2026 |
| Truist Securities | Maintained | Buy | $320 $350 | Jul 31, 2026 |
| Barclays | Maintained | Equal-Weight | $290 $320 | Jul 31, 2026 |
| B of A Securities | Maintained | Buy | $300 $320 | Jul 13, 2026 |
| Baird | Maintained | Outperform | $335 $338 | Jul 13, 2026 |
| Evercore ISI Group | Maintained | Outperform | $280 $300 | Apr 8, 2026 |
| Piper Sandler | Maintained | Neutral | $270 $300 | Feb 24, 2026 |
| JP Morgan | Maintained | Overweight | $319 $330 | Feb 18, 2026 |
| Baird | Maintained | Outperform | $313 $326 | Feb 18, 2026 |
| JP Morgan | Maintained | Overweight | $317 $319 | Feb 6, 2026 |
| JP Morgan | Maintained | Overweight | $291 $317 | Nov 7, 2025 |
| UBS | Maintained | Buy | $325 $320 | Oct 29, 2025 |
| UBS | Maintained | Buy | $305 $325 | Oct 17, 2025 |
| Mizuho | Maintained | Outperform | $285 $320 | Oct 17, 2025 |
| Evercore ISI Group | Maintained | Outperform | $300 $305 | Oct 3, 2025 |
| Barclays | Maintained | Equal-Weight | $275 $290 | Oct 2, 2025 |
| Truist Securities | Maintained | Buy | $290 $310 | Jul 25, 2025 |
| UBS | Maintained | Buy | $282 $305 | Jul 25, 2025 |
| Evercore ISI Group | Maintained | Outperform | $285 $300 | Jul 25, 2025 |
| Morgan Stanley | Maintained | Overweight | $283 $306 | Jul 25, 2025 |
146 filings from 28 insiders · 3 buy / 8 sell over 6m
Officers and directors of LH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Oyegunwa AkinboladeOfficer, EVP, CIO & CTO | GrantRestricted Stock Unit | 750 | — | — | Sep 1, 2026 |
| Meltzer Jonathan COfficer, EVP, COO | GrantRestricted Stock Unit | 900 | — | — | Sep 1, 2026 |
| Vaughn Bryan TOfficer, EVP and President, Diagnostics | GrantRestricted Stock Unit | 1.5k | — | — | Sep 1, 2026 |
| Caveney Brian JOfficer, EVP, Pres of BLS, CMO & CSO | GrantRestricted Stock Unit | 3.0k | — | — | Sep 1, 2026 |
| ANDERSON KERRII BDirector | Sell | 3.0k | $318.02 | $954k | Aug 17, 2026 |
| SCHECHTER ADAM HChief Executive Officer | Sell | 4.7k | $320.37 | $1.50M | Aug 11, 2026 |
| SUMMY AMY BOfficer | Sell | 924 | $306.74 | $283k | Aug 4, 2026 |
| WILKINSON PETER JOfficer | Exercise | 1.3k | $209.25 | $280k | Aug 3, 2026 |
| WILKINSON PETER JOfficer | Sell | 1.4k | $309.22 | $439k | Aug 3, 2026 |
| KYLE KATHRYN WOfficer | Sell | 92 | $286.19 | $26k | Jul 2, 2026 |
| VAUGHN BRYAN TOfficer | Sell | 234 | $286.19 | $67k | Jul 2, 2026 |
| KYLE KATHRYN WOfficer | Other | 256 | — | — | Jul 1, 2026 |
| VAUGHN BRYAN TOfficer | Other | 327 | — | — | Jul 1, 2026 |
| KYLE KATHRYN WOfficer | Sell | 762 | $263.89 | $201k | Jun 8, 2026 |
| SCHECHTER ADAM HChief Executive Officer | Sell | 5.9k | $254.50 | $1.50M | May 11, 2026 |
| MELTZER JONATHAN COfficer | Sell | 839 | $267.05 | $224k | Mar 27, 2026 |
| WILKINSON PETER JOfficer | Sell | 1.6k | $267.05 | $436k | Mar 27, 2026 |
| SCHROEDER MARK SChief Operating Officer | Grant | 12.3k | — | — | Mar 26, 2026 |
| SUMMY AMY BOfficer | Grant | 4.0k | — | — | Mar 26, 2026 |
| BAILEY MEGAN DOfficer | Grant | 1.2k | — | — | Mar 26, 2026 |
No analyst notes on LH yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 11 | 4 | 0 | 1 | Buy2.28 |
| 1 mo ago | 2 | 11 | 4 | 0 | 1 | Buy2.28 |
| 2 mo ago | 2 | 11 | 4 | 0 | 1 | Buy2.28 |
| 3 mo ago | 2 | 11 | 5 | 0 | 0 | Buy2.17 |
Members whose judged calls on LH have played out most reliably.
No settled calls on LH yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice